Baker Bros. Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2011 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 101,047 | 0 | 4,751 | 105.8 K to 4.8 K (-95.51 %) |
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 1,000.00 | 600 | 600,000 | 600 | |
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 0.04 | 300 | 12 | 300 | |
| Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 21.98 | 309 | 6,792 | 6,992 | 6.7 K to 7 K (+4.62 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.18 | 14 | 17 | 2,902 | 2.9 K to 2.9 K (-0.48 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.19 | 33 | 39 | 2,916 | 2.9 K to 2.9 K (-1.12 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.30 | 21 | 27 | 2,949 | 3 K to 2.9 K (-0.71 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.28 | 9 | 11 | 2,970 | 3 K to 3 K (-0.30 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.86 | 5,722 | 85,033 | 239,258 | 245 K to 239.3 K (-2.34 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.71 | 7,233 | 106,410 | 244,980 | 252.2 K to 245 K (-2.87 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.94 | 19,433 | 290,387 | 252,213 | 271.6 K to 252.2 K (-7.15 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.00 | 1,856 | 25,980 | 271,646 | 273.5 K to 271.6 K (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.00 | 956 | 13,384 | 273,502 | 274.5 K to 273.5 K (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.08 | 6,053 | 85,234 | 274,458 | 280.5 K to 274.5 K (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | S | 14.09 | 3,938 | 55,476 | 280,511 | 284.4 K to 280.5 K (-1.38 %) |
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.75 | 798 | 8,579 | 481,890 | 481.1 K to 481.9 K (+0.17 %) |
| Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.60 | 1 | 20 | 194,184 | 194.2 K to 194.2 K (0.00 %) |
| Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.99 | 33 | 660 | 194,183 | 194.2 K to 194.2 K (+0.02 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.70 | 14 | 276 | 194,150 | 194.1 K to 194.2 K (+0.01 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.36 | 5 | 97 | 194,136 | 194.1 K to 194.1 K (0.00 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.37 | 16 | 310 | 194,131 | 194.1 K to 194.1 K (+0.01 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.48 | 4 | 78 | 194,115 | 194.1 K to 194.1 K (0.00 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.50 | 6 | 117 | 194,111 | 194.1 K to 194.1 K (0.00 %) |
| May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.10 | 2 | 12 | 105,798 | 105.8 K to 105.8 K (0.00 %) |
| May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,796 | 105.8 K to 105.8 K (+0.01 %) |
| May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,785 | 105.8 K to 105.8 K (+0.01 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 31 | 186 | 105,774 | 105.7 K to 105.8 K (+0.03 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.98 | 21 | 126 | 105,743 | 105.7 K to 105.7 K (+0.02 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.99 | 15 | 90 | 105,722 | 105.7 K to 105.7 K (+0.01 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.84 | 3 | 18 | 105,707 | 105.7 K to 105.7 K (0.00 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.87 | 10 | 59 | 105,704 | 105.7 K to 105.7 K (+0.01 %) |
| May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 28 | 168 | 105,694 | 105.7 K to 105.7 K (+0.03 %) |
| May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 190 | 1,037 | 105,666 | 105.5 K to 105.7 K (+0.18 %) |
| May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 44 | 240 | 105,476 | 105.4 K to 105.5 K (+0.04 %) |
| May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.45 | 45 | 245 | 105,432 | 105.4 K to 105.4 K (+0.04 %) |
| May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.86 | 61 | 357 | 105,387 | 105.3 K to 105.4 K (+0.06 %) |
| May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.92 | 83 | 492 | 105,326 | 105.2 K to 105.3 K (+0.08 %) |
| May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.73 | 48 | 275 | 105,243 | 105.2 K to 105.2 K (+0.05 %) |
| May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.72 | 90 | 515 | 105,195 | 105.1 K to 105.2 K (+0.09 %) |
| May 20 2009 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.72 | 3,710 | 36,061 | 481,092 | 477.4 K to 481.1 K (+0.78 %) |
| May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.82 | 3 | 53 | 194,105 | 194.1 K to 194.1 K (0.00 %) |
| May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.00 | 12 | 216 | 194,102 | 194.1 K to 194.1 K (+0.01 %) |
| May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.88 | 1 | 18 | 194,090 | 194.1 K to 194.1 K (0.00 %) |
| May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.98 | 9 | 162 | 194,089 | 194.1 K to 194.1 K (0.00 %) |
| May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.36 | 6 | 116 | 194,080 | 194.1 K to 194.1 K (0.00 %) |
| May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.51 | 27 | 527 | 194,074 | 194 K to 194.1 K (+0.01 %) |
| May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.67 | 19 | 374 | 194,047 | 194 K to 194 K (+0.01 %) |
| May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.54 | 27 | 528 | 194,028 | 194 K to 194 K (+0.01 %) |
| May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.53 | 9 | 176 | 194,001 | 194 K to 194 K (0.00 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.89 | 3,124 | 12,137 | 71,997 | 75.1 K to 72 K (-4.16 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.86 | 8,067 | 31,172 | 75,121 | 83.2 K to 75.1 K (-9.70 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.12 | 7,726 | 31,853 | 83,188 | 90.9 K to 83.2 K (-8.50 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.30 | 1,500 | 6,452 | 90,914 | 92.4 K to 90.9 K (-1.62 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.50 | 11,128 | 50,122 | 92,414 | 103.5 K to 92.4 K (-10.75 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.45 | 6,174 | 27,496 | 103,542 | 109.7 K to 103.5 K (-5.63 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 64,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 335,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 1,000 | 11,219 | 333,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.16 | 5 | 11 | 284,449 | 284.4 K to 284.4 K (0.00 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.14 | 5 | 11 | 284,444 | 284.4 K to 284.4 K (0.00 %) |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 4,000 | 44,872 | 332,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 1,000 | 11,219 | 328,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 327,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 4,000 | 44,874 | 325,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.17 | 8 | 17 | 284,439 | 284.4 K to 284.4 K (0.00 %) |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.14 | 9 | 19 | 284,431 | 284.4 K to 284.4 K (0.00 %) |
| Jan 23 2009 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 1,084 | 0 | 136,010 | 137.1 K to 136 K (-0.79 %) |
| Jan 23 2009 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 26,982 | 0 | 137,094 | 164.1 K to 137.1 K (-16.44 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 212 | 1,733 | 1,629 | 1.8 K to 1.6 K (-11.52 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.11 | 40 | 324 | 1,841 | 1.9 K to 1.8 K (-2.13 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 10 | 82 | 1,881 | 1.9 K to 1.9 K (-0.53 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.16 | 55 | 449 | 1,891 | 1.9 K to 1.9 K (-2.83 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.46 | 207 | 1,751 | 1,946 | 2.2 K to 1.9 K (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.47 | 22 | 186 | 2,153 | 2.2 K to 2.2 K (-1.01 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 9.03 | 2 | 18 | 2,175 | 2.2 K to 2.2 K (-0.09 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.01 | 81 | 649 | 2,177 | 2.3 K to 2.2 K (-3.59 %) |
| Jan 23 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 2,901 | 0 | 2,258 | 5.2 K to 2.3 K (-56.23 %) |
| Jan 23 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 72,217 | 0 | 5,159 | 77.4 K to 5.2 K (-93.33 %) |
| Oct 21 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | J | 2.74 | 27 | 74 | 125,492 | 125.5 K to 125.5 K (+0.02 %) |
| Oct 17 2008 | NPRO | TAPESTRY PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 0.00 | 5,573 | 6 | 0 | 5.6 K to 0 (-100.00 %) |
| Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 9,904 | 0 | 0 | |
| Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 257,504 | 0 | 690,856 | 433.4 K to 690.9 K (+59.42 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 6,000 | 67,320 | 74,000 | |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 11,000 | 123,420 | 11,000 | |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.60 | 1,235 | 4,440 | 285,479 | 284.2 K to 285.5 K (+0.43 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.62 | 219 | 792 | 284,244 | 284 K to 284.2 K (+0.08 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.56 | 125 | 445 | 284,025 | 283.9 K to 284 K (+0.04 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.60 | 8 | 29 | 283,900 | 283.9 K to 283.9 K (0.00 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.33 | 184 | 613 | 283,892 | 283.7 K to 283.9 K (+0.06 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.33 | 112 | 373 | 283,708 | 283.6 K to 283.7 K (+0.04 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.15 | 13 | 41 | 283,596 | 283.6 K to 283.6 K (0.00 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.98 | 10 | 10 | 109,716 | 109.7 K to 109.7 K (+0.01 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.91 | 43 | 39 | 109,706 | 109.7 K to 109.7 K (+0.04 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 1.00 | 422 | 422 | 109,663 | 109.2 K to 109.7 K (+0.39 %) |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 11.14 | 205 | 2,284 | 205 | |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 11.14 | 820 | 9,135 | 164,076 | 163.3 K to 164.1 K (+0.50 %) |
| Aug 05 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 1,539 | 13,851 | 283,583 | 282 K to 283.6 K (+0.55 %) |
| Jul 30 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.93 | 1,885 | 28,145 | 40,077 | 42 K to 40.1 K (-4.49 %) |
| Jul 30 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.87 | 565 | 8,403 | 41,962 | 42.5 K to 42 K (-1.33 %) |
| Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.01 | 1,768 | 26,541 | 42,527 | 44.3 K to 42.5 K (-3.99 %) |
| Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.02 | 2,947 | 44,267 | 44,295 | 47.2 K to 44.3 K (-6.24 %) |
| Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.86 | 1,886 | 28,024 | 47,242 | 49.1 K to 47.2 K (-3.84 %) |
| Jul 21 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.80 | 3,535 | 52,318 | 49,128 | 52.7 K to 49.1 K (-6.71 %) |
| Jul 16 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.24 | 1,645 | 25,072 | 52,663 | 54.3 K to 52.7 K (-3.03 %) |
| Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.51 | 943 | 13,686 | 54,308 | 55.3 K to 54.3 K (-1.71 %) |
| Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 14.99 | 2,416 | 36,222 | 55,251 | 57.7 K to 55.3 K (-4.19 %) |
| Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.41 | 31,791 | 489,899 | 57,667 | 89.5 K to 57.7 K (-35.54 %) |
| May 30 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 697 | 0 | 125,465 | 126.2 K to 125.5 K (-0.55 %) |
| May 30 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 17,965 | 0 | 126,162 | 144.1 K to 126.2 K (-12.46 %) |
| May 30 2008 | NPRO | TAPESTRY PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 1,512 | 0 | 5,573 | 7.1 K to 5.6 K (-21.34 %) |
| May 30 2008 | NPRO | TAPESTRY PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 34,035 | 0 | 7,085 | 41.1 K to 7.1 K (-82.77 %) |
| Apr 08 2008 | NPRO | TAPESTRY PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 0.11 | 521 | 58 | 41,120 | 41.6 K to 41.1 K (-1.25 %) |
| Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 2.30 | 9,904 | 22,779 | 9,904 | |
| Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 0.00 | 9,904 | 0 | 9,904 | |
| May 30 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 1,218 | 0 | 163,256 | 164.5 K to 163.3 K (-0.74 %) |
| May 30 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 30,288 | 0 | 164,474 | 194.8 K to 164.5 K (-15.55 %) |
| May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | C | 0.00 | 11 | 0 | 0 | |
| May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | C | 0.00 | 57,873 | 0 | 194,762 | 136.9 K to 194.8 K (+42.28 %) |
| Apr 21 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 13.28 | 76 | 1,009 | 136,889 | 136.8 K to 136.9 K (+0.06 %) |
| Apr 08 2008 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 13.28 | 753 | 10,000 | 136,813 | 136.1 K to 136.8 K (+0.55 %) |
| May 30 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 4,610 | 0 | 77,376 | 82 K to 77.4 K (-5.62 %) |
| May 30 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 109,834 | 0 | 81,986 | 191.8 K to 82 K (-57.26 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.14 | 15 | 122 | 144,127 | 144.1 K to 144.1 K (+0.01 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.67 | 9 | 78 | 144,112 | 144.1 K to 144.1 K (+0.01 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.69 | 134 | 1,165 | 144,103 | 144 K to 144.1 K (+0.09 %) |
| Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.95 | 192 | 1,718 | 143,969 | 143.8 K to 144 K (+0.13 %) |
| Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.76 | 281 | 2,461 | 143,777 | 143.5 K to 143.8 K (+0.20 %) |
| Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.02 | 141 | 1,131 | 477,382 | 477.2 K to 477.4 K (+0.03 %) |
| Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.80 | 189 | 1,474 | 477,241 | 477.1 K to 477.2 K (+0.04 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.06 | 105 | 846 | 477,052 | 476.9 K to 477.1 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.08 | 225 | 1,819 | 476,947 | 476.7 K to 476.9 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.93 | 103 | 816 | 476,722 | 476.6 K to 476.7 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.98 | 31 | 247 | 476,619 | 476.6 K to 476.6 K (+0.01 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.06 | 105 | 846 | 477,052 | 476.9 K to 477.1 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.08 | 225 | 1,819 | 476,947 | 476.7 K to 476.9 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.93 | 103 | 816 | 476,722 | 476.6 K to 476.7 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.98 | 31 | 247 | 476,619 | 476.6 K to 476.6 K (+0.01 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.06 | 103 | 933 | 476,588 | 476.5 K to 476.6 K (+0.02 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.94 | 4 | 36 | 476,485 | 476.5 K to 476.5 K (0.00 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 238 | 2,143 | 476,481 | 476.2 K to 476.5 K (+0.05 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 70 | 630 | 476,243 | 476.2 K to 476.2 K (+0.01 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.03 | 259 | 2,338 | 476,173 | 475.9 K to 476.2 K (+0.05 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.78 | 160 | 1,404 | 475,914 | 475.8 K to 475.9 K (+0.03 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 4,747 | 42,723 | 475,754 | 471 K to 475.8 K (+1.01 %) |
| Jan 31 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 48,000 | 538,488 | 365,000 | |
| Jan 31 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 317,000 | |
| Jan 24 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.62 | 1 | 11 | 282,044 | 282 K to 282 K (0.00 %) |
| Jan 16 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.99 | 94 | 1,033 | 282,043 | 281.9 K to 282 K (+0.03 %) |
| Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.94 | 84 | 919 | 281,949 | 281.9 K to 281.9 K (+0.03 %) |
| Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 11.01 | 3 | 33 | 281,865 | 281.9 K to 281.9 K (0.00 %) |